You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 296 No. 2, July 12, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Pregnancy and Breast Feeding
 •Psychiatry
 •Depression
 •Alert me on articles by topic

Antidepressant Treatment and Relapse of Depression During Pregnancy

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: I am concerned regarding the apparent failure to provide appropriate financial disclosures by 7 of the coauthors of the study on relapse of major depression during pregnancy related to antidepressant use by Dr Cohen and colleagues.1 This article deals in part with what happens when women discontinue their antidepressants during pregnancy. It is therefore essential that readers be aware that the majority of the authors have been paid by companies that manufacture antidepressants, and that the lead author appears to have received support from at least 8 such companies.

In 2004, Dr Cohen declared that he received support from AstraZeneca, Berlex, Eli Lilly, Forest, GlaxoSmithKline, Janssen, Pfizer, and Wyeth. Dr Nonacs and Dr Viguera declared that they were on the speakers bureau of GlaxoSmithKline.2 In 2003, Dr Altshuler disclosed support from Abbott Laboratories, Eli Lilly, Forest Pharmaceuticals, Janssen Pharmaceutica, Solvay, and Bristol-Myers Squibb.3 In 2004, Dr Suri . . . [Full Text of this Article]

Adam C. Urato, MD
aurato@tufts-nemc.org
Department of Obstetrics and Gynecology
Tufts University-New England Medical Center
Boston, Mass


RELATED ARTICLES

Antidepressant Treatment and Relapse of Depression During Pregnancy
Takeshi Terao
JAMA. 2006;296(2):165.
EXTRACT | FULL TEXT  

Antidepressant Treatment and Relapse of Depression During Pregnancy
Arthur Rifkin and William Rifkin
JAMA. 2006;296(2):165-166.
EXTRACT | FULL TEXT  

Antidepressant Treatment and Relapse of Depression During Pregnancy—Reply
Lee S. Cohen, Ruta Nonacs, Adele C. Viguera, Alison M. Reminick, Lori L. Altshuler, Rita Suri, Vivien K. Burt, Victoria Hendrick, Bernard L. Harlow, Allison F. Vitonis, D. Jeffrey Newport, Ada Loughead, and Zachary N. Stowe
JAMA. 2006;296(2):166-167.
EXTRACT | FULL TEXT  

Relapse of Major Depression During Pregnancy in Women Who Maintain or Discontinue Antidepressant Treatment
Lee S. Cohen, Lori L. Altshuler, Bernard L. Harlow, Ruta Nonacs, D. Jeffrey Newport, Adele C. Viguera, Rita Suri, Vivien K. Burt, Victoria Hendrick, Alison M. Reminick, Ada Loughead, Allison F. Vitonis, and Zachary N. Stowe
JAMA. 2006;295(5):499-507.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Commercially Funded and United States-Based Research Is More Likely to Be Published; Good-Quality Studies with Negative Outcomes Are Not
Lynch et al.
JBJS 2007;89:1010-1018.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.